ES2966170T3 - Transdermal therapeutic system comprising rotigotine and at least one non-amine resistant silicone adhesive - Google Patents
Transdermal therapeutic system comprising rotigotine and at least one non-amine resistant silicone adhesiveInfo
- Publication number
- ES2966170T3 ES2966170T3 ES20153621T ES20153621T ES2966170T3 ES 2966170 T3 ES2966170 T3 ES 2966170T3 ES 20153621 T ES20153621 T ES 20153621T ES 20153621 T ES20153621 T ES 20153621T ES 2966170 T3 ES2966170 T3 ES 2966170T3
- Authority
- ES
- Spain
- Prior art keywords
- rotigotine
- silicone adhesive
- therapeutic system
- transdermal therapeutic
- resistant silicone
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 150000001412 amines Chemical class 0.000 title 1
- KFQYTPMOWPVWEJ-INIZCTEOSA-N rotigotine Chemical compound CCCN([C@@H]1CC2=CC=CC(O)=C2CC1)CCC1=CC=CS1 KFQYTPMOWPVWEJ-INIZCTEOSA-N 0.000 title 1
- 229960003179 rotigotine Drugs 0.000 title 1
- 239000013464 silicone adhesive Substances 0.000 title 1
- 230000001225 therapeutic effect Effects 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7069—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained otherwise than by reactions only involving carbon to carbon unsaturated bonds, e.g. polysiloxane, polyesters, polyurethane, polyethylene oxide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
- A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP20153621.6A EP3854388B1 (en) | 2020-01-24 | 2020-01-24 | Transdermal therapeutic system comprising rotigotine and at least one non-amine-resistant silicone adhesive |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2966170T3 true ES2966170T3 (en) | 2024-04-18 |
Family
ID=69191982
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES20153621T Active ES2966170T3 (en) | 2020-01-24 | 2020-01-24 | Transdermal therapeutic system comprising rotigotine and at least one non-amine resistant silicone adhesive |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US20230218539A1 (en) |
| EP (2) | EP3854388B1 (en) |
| JP (1) | JP2023511964A (en) |
| KR (1) | KR20220131941A (en) |
| CN (1) | CN115279351A (en) |
| AU (1) | AU2021210611A1 (en) |
| BR (1) | BR112022014665A2 (en) |
| CA (1) | CA3165453A1 (en) |
| CL (1) | CL2022001988A1 (en) |
| CO (1) | CO2022011900A2 (en) |
| DK (1) | DK3854388T3 (en) |
| ES (1) | ES2966170T3 (en) |
| FI (1) | FI3854388T3 (en) |
| MX (1) | MX2022009114A (en) |
| PL (1) | PL3854388T3 (en) |
| PT (1) | PT3854388T (en) |
| WO (1) | WO2021148634A1 (en) |
Family Cites Families (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4655767A (en) | 1984-10-29 | 1987-04-07 | Dow Corning Corporation | Transdermal drug delivery devices with amine-resistant silicone adhesives |
| US4591622A (en) | 1984-10-29 | 1986-05-27 | Dow Corning Corporation | Silicone pressure-sensitive adhesive process and product thereof |
| US5989586A (en) | 1992-10-05 | 1999-11-23 | Cygnus, Inc. | Two-phase matrix for sustained release drug delivery device |
| DE19814084B4 (en) | 1998-03-30 | 2005-12-22 | Lts Lohmann Therapie-Systeme Ag | D2 agonist-containing transdermal therapeutic system for the treatment of Parkinson's syndrome and process for its preparation |
| DE19830898A1 (en) | 1998-07-10 | 2000-01-13 | Hexal Ag | Device for improving the removal ability of flat, substrate-packed sections packed in pouches with a pressure-sensitive adhesive |
| US6337086B1 (en) | 1999-02-06 | 2002-01-08 | Dow Corning Corporation | Pressure sensitive adhesive compositions for transdermal drug delivery devices |
| ES2410532T3 (en) | 2000-09-19 | 2013-07-02 | Henkel Ag & Co. Kgaa | Acryl adhesive useful in transdermal drug delivery systems |
| DE60100595T2 (en) | 2001-05-08 | 2004-06-24 | Lts Lohmann Therapie-Systeme Ag | Improved transdermal therapeutic system for the treatment of Parkinson's disease |
| DK1256339T3 (en) | 2001-05-08 | 2004-02-09 | Sanol Arznei Schwarz Gmbh | Transdermal therapeutic system for obtaining high plasma levels of rotigotine in the treatment of Parkinson's disease |
| DE10220230A1 (en) | 2002-05-06 | 2003-11-27 | Sanol Arznei Schwarz Gmbh | Use of Rotigotine to treat restless leg syndrome |
| EP1386605A1 (en) | 2002-07-30 | 2004-02-04 | Schwarz Pharma Ag | Improved transdermal delivery system for the administration of rotigotine |
| EP1386604A1 (en) | 2002-07-30 | 2004-02-04 | Schwarz Pharma Ag | Improved transdermal delivery system |
| DE10234673B4 (en) | 2002-07-30 | 2007-08-16 | Schwarz Pharma Ag | Hot-melt TTS for the administration of rotigotine and process for its preparation, and use of rotigotine in the manufacture of a hot-melt TTS |
| DE10261696A1 (en) | 2002-12-30 | 2004-07-15 | Schwarz Pharma Ag | Device for the transdermal administration of rotigotine base |
| DE10334188B4 (en) | 2003-07-26 | 2007-07-05 | Schwarz Pharma Ag | Use of rotigotine to treat depression |
| DE10361259A1 (en) | 2003-12-24 | 2005-07-28 | Schwarz Pharma Ag | Use of Rotigotine in Early Stage Parkinson's Disease to Prevent Further Neuronal Loss |
| DE102004014841B4 (en) | 2004-03-24 | 2006-07-06 | Schwarz Pharma Ag | Use of rotigotine for the treatment and prevention of Parkinson-Plus syndrome |
| KR101694551B1 (en) | 2007-11-28 | 2017-01-09 | 유씨비 파마 게엠베하 | Polymorphic form of rotigotine |
| NZ589542A (en) | 2008-05-30 | 2012-10-26 | Mylan Inc | Transdermal drug delivery system comprising an active agent in amorphous form and polyvinylpyrrolidone |
| DE102009052972A1 (en) | 2009-11-12 | 2011-09-15 | Lts Lohmann Therapie-Systeme Ag | Process for preventing the crystallization of drugs in a polymer film |
| LT2515887T (en) | 2009-12-22 | 2018-08-10 | Ucb Biopharma Sprl | Polyvinylpyrrolidone for the stabilization of a solid dispersion of the non-crystalline form of rotigotine |
| EP2457565A1 (en) | 2010-11-29 | 2012-05-30 | Ratiopharm GmbH | Transdermal therapeutic system containing rotigotin |
| WO2012084969A1 (en) | 2010-12-22 | 2012-06-28 | Hexal Ag | Adhesive composition containing rotigotine and transdermal therapeutic system comprising the adhesive composition |
| TW201431570A (en) * | 2012-11-22 | 2014-08-16 | Ucb Pharma Gmbh | Multi-day patch for the transdermal administration of rotigotine |
| US20160199316A1 (en) * | 2013-06-14 | 2016-07-14 | Tesa Labtec Gmbh | Three-layer transdermal therapy system (tts) |
| CA2948219C (en) * | 2014-05-20 | 2023-04-04 | Lts Lohmann Therapie-Systeme Ag | Method for adjusting the release of active agent in a transdermal delivery system |
-
2020
- 2020-01-24 FI FIEP20153621.6T patent/FI3854388T3/en active
- 2020-01-24 PL PL20153621.6T patent/PL3854388T3/en unknown
- 2020-01-24 DK DK20153621.6T patent/DK3854388T3/en active
- 2020-01-24 EP EP20153621.6A patent/EP3854388B1/en active Active
- 2020-01-24 PT PT201536216T patent/PT3854388T/en unknown
- 2020-01-24 ES ES20153621T patent/ES2966170T3/en active Active
-
2021
- 2021-01-22 WO PCT/EP2021/051500 patent/WO2021148634A1/en active Application Filing
- 2021-01-22 JP JP2022545040A patent/JP2023511964A/en active Pending
- 2021-01-22 MX MX2022009114A patent/MX2022009114A/en unknown
- 2021-01-22 EP EP21702196.3A patent/EP4093383A1/en active Pending
- 2021-01-22 BR BR112022014665A patent/BR112022014665A2/en unknown
- 2021-01-22 US US17/794,886 patent/US20230218539A1/en active Pending
- 2021-01-22 KR KR1020227027387A patent/KR20220131941A/en active Search and Examination
- 2021-01-22 AU AU2021210611A patent/AU2021210611A1/en active Pending
- 2021-01-22 CA CA3165453A patent/CA3165453A1/en active Pending
- 2021-01-22 CN CN202180021203.7A patent/CN115279351A/en active Pending
-
2022
- 2022-07-22 CL CL2022001988A patent/CL2022001988A1/en unknown
- 2022-08-22 CO CONC2022/0011900A patent/CO2022011900A2/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| PL3854388T3 (en) | 2024-02-26 |
| CA3165453A1 (en) | 2021-07-29 |
| PT3854388T (en) | 2023-12-11 |
| EP3854388B1 (en) | 2023-10-04 |
| CN115279351A (en) | 2022-11-01 |
| MX2022009114A (en) | 2022-10-27 |
| EP3854388A1 (en) | 2021-07-28 |
| JP2023511964A (en) | 2023-03-23 |
| CO2022011900A2 (en) | 2022-10-31 |
| KR20220131941A (en) | 2022-09-29 |
| US20230218539A1 (en) | 2023-07-13 |
| EP4093383A1 (en) | 2022-11-30 |
| AU2021210611A1 (en) | 2022-08-18 |
| BR112022014665A2 (en) | 2022-10-11 |
| DK3854388T3 (en) | 2023-11-27 |
| FI3854388T3 (en) | 2023-11-27 |
| CL2022001988A1 (en) | 2023-05-19 |
| WO2021148634A1 (en) | 2021-07-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ECSP088469A (en) | TRANSDERMAL THERAPEUTIC SYSTEM | |
| BRPI0910740A2 (en) | transdermal therapeutic system for the administration of fentanyl or an analogue thereof | |
| BR112017002562A2 (en) | graphene-reinforced polymer matrix compounds, engine part using it and method of preparation thereof | |
| BR112014032458A2 (en) | medical dressings and method of attaching a medical device | |
| MA46783A (en) | T-CELL THERAPY AND BTK INHIBITOR POLYTHERAPY | |
| DK3406491T3 (en) | WASTEWATER HANDLING SYSTEM INCLUDING A TOILET SUBSYSTEM AND CORRESPONDING PROCEDURE | |
| BRPI0811870A2 (en) | INFLUENCE TREATMENT AND PREVENTION | |
| BR112012005629A2 (en) | transdermal therapeutic system for administering fentanyl or an analogue thereof | |
| BR112013012313A2 (en) | paclitaxel pharmaceutical combination and a cdk inhibitor | |
| CL2014002790A1 (en) | Method of prevention or treatment of oxycodone-induced intestinal dysfunction comprising administering buprenorphine concomitantly with oxycodone hydrochloride; unit of pharmaceutical dose; kit comprising a dose unit of buprenorphine and another of oxycodone hydrochloride; transdermal buprenorphine system. | |
| MX2020003667A (en) | Transdermal therapeutic system for the transdermal administration of guanfacine comprising a silicone polymer. | |
| ES2966170T3 (en) | Transdermal therapeutic system comprising rotigotine and at least one non-amine resistant silicone adhesive | |
| DE112020004819A5 (en) | Display device and display unit | |
| ES2966229T3 (en) | Immobilization system of a medical robot | |
| ES1258354Y (en) | Tattoo practice device | |
| MA54190A (en) | INTRA-UTERINE DILATION DEVICE | |
| IT201900010341A1 (en) | Device, system and method of treatment of a corneal tissue | |
| BR112019023393A2 (en) | TRANSDERMAL THERAPEUTIC SYSTEM CONTAINING SCOPOLAMIN AND HYBRID ACRYLIC AND SILICON POLYMER | |
| ES1261684Y (en) | ADHESIVE PROTECTIVE MASK | |
| ES1279895Y (en) | Advertising support device or similar | |
| ES1139556Y (en) | BANDAGE FOR THE TREATMENT OF ARTICULAR PAIN THAT INCLUDES AT LEAST TWO TRANSDERMAL PATCHES. | |
| TWI799996B (en) | Electrostatic decontamination device | |
| ES1296755Y (en) | SYSTEM INCLUDING A STRUCTURE AND AT LEAST TWO IDENTICAL TWO-DIMENSIONAL CODES | |
| ES1297315Y (en) | PATIENT CONTAINMENT DEVICE | |
| IT201900022359A1 (en) | DEVICE FOR THE VERIFICATION AND CONTROL OF DENTAL ARCHES |